Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

IJIR publishes special/guest-edited issues and topical collections. The peer review process for articles included in topical collections/special issues is the same as the peer review process of the journal in general. Additionally, if the Guest Editors author an article in their topical collection/special issue, they will not handle the peer review process.​

“Can we try to avoid surgery first?”—Real-world experience with surgery for Peyronie’s disease in the post-intralesional collagenase setting

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout


  1. Zhang F, Xiong Y, Wang W, Wu C, Qin F, Yuan J. The efficacy and safety of intralesional injection of collagenase Clostridium histolyticum for Peyronie’s disease: a meta-analysis of published prospective studies. Front Pharmacol. 2022;13:973394.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Li MK, Sigalos JT, Yoffe DA, Modiri N, Hu MY, Gaither TW, et al. Multiple courses of intralesional collagenase injections for Peyronie disease: a retrospective analysis. J Sex Med. 2023;20:200–4.

    Article  PubMed  Google Scholar 

  3. Levine LA, Larsen SM. Surgical correction of persistent Peyronie’s disease following collagenase Clostridium histolyticum treatment. J Sex Med. 2015;12:259–64.

    Article  PubMed  Google Scholar 

  4. Cocci A, Ralph D, Djinovic R, Hatzichristodoulou G, Morelli G, Salonia A, et al. Surgical outcomes after collagenase Clostridium histolyticum failure in patients with Peyronie’s disease in a multicenter clinical study. Sci Rep. 2021;11:166.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Wymer K, Kohler T, Trost L. Comparative cost-effectiveness of surgery, collagenase clostridium histolyticum, and penile traction therapy in men with Peyronie’s disease in an era of effective clinical treatment. J Sex Med. 2019;16:1421–32.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations



Conceptualization: RK, JNM, and SVE; Data curation: RK and KVR; Formal analysis: RK, JNM, and SVE; Investigation: RK, KVR, JNM, and SVE; Project administration: RK, KVR, JNM, and SVE; Supervision: JNM and SVE; Visualization: RK and SVE; Writing – original draft: RK, KVR, JNM, and SVE. Writing – review & editing: RK, KVR, JNM, and SVE.

Corresponding author

Correspondence to Sriram V. Eleswarapu.

Ethics declarations

Competing interests

JNM serves as a consultant to Boston Scientific Corporation, Endo Pharmaceuticals, and Halozyme Therapeutics and receives compensation. KVR serves as a speaker for Boston Scientific Corporation and Halozyme Therapeutics and receives compensation. RK and SVE declare no potential conflicts of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kianian, R., Regets, K.V., Mills, J.N. et al. “Can we try to avoid surgery first?”—Real-world experience with surgery for Peyronie’s disease in the post-intralesional collagenase setting. Int J Impot Res (2023).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI:


Quick links